Apo-Ghrelin Receptor Forms Heteromers with DRD2 in Hypothalamic Neurons and Is Essential for Anorexigenic Effects of DRD2 Agonism

Neuron

Volumn 73, Issue 2, 2012, Pages 317-332

  Kern, Andras ^a   Albarran Zeckler, Rosie ^a   Walsh, HeidiE ^a   Smith, RoyG ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; GHRELIN RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CELL SUBPOPULATION; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CALCIUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ERGOLINES; GHRELIN; HYPOTHALAMUS; MICE; NEURONS; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION;

EID: 84863010954     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.10.038     Document Type: Article

References (53)

1. Albizu L., Cottet M., Kralikova M., Stoev S., Seyer R., Brabet I., Roux T., Bazin H., Bourrier E., Lamarque L., et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat. Chem. Biol. 2010, 6:587-594.
2. Bonacci T.M., Mathews J.L., Yuan C., Lehmann D.M., Malik S., Wu D., Font J.L., Bidlack J.M., Smrcka A.V. Differential targeting of Gbetagamma-subunit signaling with small molecules. Science 2006, 312:443-446.
3. Bulenger S., Marullo S., Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 2005, 26:131-137.
4. Button D., Brownstein M. Aequorin-expressing mammalian cell lines used to report Ca2+ mobilization. Cell Calcium 1993, 14:663-671.
5. Canals M., Milligan G. Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors. J.Biol. Chem. 2008, 283:11424-11434.
6. Comings D.E., Gade R., MacMurray J.P., Muhleman D., Peters W.R. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol. Psychiatry 1996, 1:325-335.
7. Costantini V.J., Vicentini E., Sabbatini F.M., Valerio E., Lepore S., Tessari M., Sartori M., Michielin F., Melotto S., Pich E.M., Corsi M. GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs. Neuroendocrinology 2011, 94:158-168.
8. Cowley M.A., Smith R.G., Diano S., Tschöp M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
9. Dixit V.D., Yang H., Sun Y., Weeraratna A.T., Youm Y.H., Smith R.G., Taub D.D. Ghrelin promotes thymopoiesis during aging. J.Clin. Invest. 2007, 117:2778-2790.
10. Epstein L.H., Temple J.L., Neaderhiser B.J., Salis R.J., Erbe R.W., Leddy J.J. Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav. Neurosci. 2007, 121:877-886.
11. Feighner S.D., Howard A.D., Prendergast K., Palyha O.C., Hreniuk D.L., Nargund R.P., Underwood D., Tata J.R., Dean D.C., Tan C.P., et al. Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol. Endocrinol. 1998, 12:137-145.
12. Feighner S.D., Tan C.P., McKee K.K., Palyha O.C., Hreniuk D.L., Pong S.-S., Austin C.P., Figueroa D., MacNeil D., Cascieri M.A., et al. Receptor for motilin identified in the human gastrointestinal system. Science 1999, 284:2184-2188.
13. Fetissov S.O., Meguid M.M., Sato T., Zhang L.H. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R905-R910.
14. Fung J.J., Deupi X., Pardo L., Yao X.J., Velez-Ruiz G.A., Devree B.T., Sunahara R.K., Kobilka B.K. Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer. EMBO J. 2009, 28:3315-3328.
15. Grouselle D., Chaillou E., Caraty A., Bluet-Pajot M.T., Zizzari P., Tillet Y., Epelbaum J. Pulsatile cerebrospinal fluid and plasma ghrelin in relation to growth hormone secretion and food intake in the sheep. J.Neuroendocrinol. 2008, 20:1138-1146.
16. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 1997, 48:23-29.
17. Guo W., Shi L., Filizola M., Weinstein H., Javitch J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc. Natl. Acad. Sci. USA 2005, 102:17495-17500.
18. Han Y., Moreira I.S., Urizar E., Weinstein H., Javitch J.A. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat. Chem. Biol. 2009, 5:688-695.
19. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J.Biol. Chem. 2004, 279:53806-53817.
20. Holst B., Mokrosinski J., Lang M., Brandt E., Nygaard R., Frimurer T.M., Beck-Sickinger A.G., Schwartz T.W. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism. J.Biol. Chem. 2007, 282:15799-15811.
21. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
22. Inglese J., Luttrell L.M., Iñiguez-Lluhi J.A., Touhara K., Koch W.J., Lefkowitz R.J. Functionally active targeting domain of the beta-adrenergic receptor kinase: an inhibitor of G beta gamma-mediated stimulation of type II adenylyl cyclase. Proc. Natl. Acad. Sci. USA 1994, 91:3637-3641.
23. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by crosstalk involving formation of GHS-R/D1R heterodimers. Mol. Endocrinol. 2006, 20:1772-1785.
24. Johnson P.M., Kenny P.J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 2010, 13:635-641.
25. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998, 396:674-679.
26. Kern A., Agoulnik A.I., Bryant-Greenwood G.D. The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane. Endocrinology 2007, 148:1181-1194.
27. Koch W.J., Hawes B.E., Inglese J., Luttrell L.M., Lefkowitz R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling. J.Biol. Chem. 1994, 269:6193-6197.
28. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
29. Korner J., Lo J., Freda P.U., Wardlaw S.L. Treatment with cabergoline is associated with weight loss in patients with hyperprolactinemia. Obes. Res. 2003, 11:311-312.
30. Kvernmo T., Härtter S., Burger E. A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clin. Ther. 2006, 28:1065-1078.
31. Mancia F., Assur Z., Herman A.G., Siegel R., Hendrickson W.A. Ligand sensitivity in dimeric associations of the serotonin 5HT2c receptor. EMBO Rep. 2008, 9:363-369.
32. Maurel D., Comps-Agrar L., Brock C., Rives M.L., Bourrier E., Ayoub M.A., Bazin H., Tinel N., Durroux T., Prézeau L., et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat. Methods 2008, 5:561-567.
33. Meguid M.M., Fetissov S.O., Varma M., Sato T., Zhang L., Laviano A., Rossi-Fanelli F. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000, 16:843-857.
34. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br. J. Pharmacol. 2009, 158:5-14.
35. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiol. Rev. 1998, 78:189-225.
36. Moulin A., Demange L., Bergé G., Gagne D., Ryan J., Mousseaux D., Heitz A., Perrissoud D., Locatelli V., Torsello A., et al. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological invitro and invivo evaluations. J.Med. Chem. 2007, 50:5790-5806.
37. Namkung Y., Sibley D.R. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J.Biol. Chem. 2004, 279:49533-49541.
38. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci. 2007, 30:375-381.
39. Patchett A.A., Nargund R.P., Tata J.R., Chen M.-H., Barakat K.J., Johnston D.B.R., Cheng K., Chan W.W.-S., Butler B.S., Hickey G.J., et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc. Natl. Acad. Sci. USA 1995, 92:7001-7005.
40. Petersen P.S., Woldbye D.P., Madsen A.N., Egerod K.L., Jin C., Lang M., Rasmussen M., Beck-Sickinger A.G., Holst B. Invivo characterization of high Basal signaling from the ghrelin receptor. Endocrinology 2009, 150:4920-4930.
41. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a " thrifty" genotype underlying the metabolic syndrome?. Eur. J. Pharmacol. 2003, 480:125-131.
42. Rives M.-L., Vol C., Fukazawa Y., Tinel N., Trinquet E., Ayoub M.A., Shigemoto R., Pin J.-P., Prézeau L. Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J. 2009, 28:2195-2208.
43. Smith N.J., Milligan G. Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol. Rev. 2010, 62:701-725.
44. Smith R.G., Pong S.-S., Hickey G.J., Jacks T.M., Cheng K., Leonard R.J., Cohen C.J., Arena J.P., Chang C.H., Drisko J.E., et al. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog. Horm. Res. 1996, 51:261-285. discussion 285-286.
45. Smith R.G., Van der Ploeg L.H., Howard A.D., Feighner S.D., Cheng K., Hickey G.J., Wyvratt M.J., Fisher M.H., Nargund R.P., Patchett A.A. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18:621-645.
46. Stice E., Spoor S., Bohon C., Small D.M. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322:449-452.
47. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 2004, 101:4679-4684.
48. Sun Y., Asnicar M., Saha P.K., Chan L., Smith R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006, 3:379-386.
49. Terrillon S., Bouvier M. Roles of G-protein-coupled receptor dimerization. EMBO Rep. 2004, 5:30-34.
50. Vilardaga J.-P., Nikolaev V.O., Lorenz K., Ferrandon S., Zhuang Z., Lohse M.J. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. Nat. Chem. Biol. 2008, 4:126-131.
51. Volkow N.D., Wang G.-J., Baler R.D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn. Sci. (Regul. Ed.) 2011, 15:37-46.
52. Vucetic Z., Reyes T.M. Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip Rev Syst Biol Med 2010, 2:577-593.
53. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J.Clin. Endocrinol. Metab. 2001, 86:5992.